Atrial fibrillation (AF) occurs in 25% to 60% of patients after cardiac surgery. It is most consistently associated with advanced age and valvular heart operations. Despite improving knowledge of the pathophysiology of chronic AF, postoperative AF remains an obstinate clinical problem. It is associated with an increased risk of stroke, longer hospital stay, and higher hospital expenditure. Consequently, there has been great interest in strategies to prevent and treat this arrhythmia. Treatment for postoperative AF may require immediate electrical cardioversion for hemodynamically unstable patients. Heart rate control is useful in most patients, with anticoagulation considered after 48 hours. Antiarrhythmic therapy is often effective in restoring sinus rhythm but its use needs to be balanced against the patient's risk of proarrhythmic side effects such as torsade de pointes.
Get full access to this article
View all access options for this article.
References
1.
FalkRH: Atrial fibrillation. N Engl J Med344:1067-1078, 2001.
2.
Benjamin EJ, Levy D, Vaziri SM, et al: Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA271:840-844, 1994.
3.
Sra J, Dhala A, Blanck Z, et al: Atrial fibrillation: epidemiology, mechanisms, and management. Curr Probl Cardiol25:405-524, 2000.
4.
Mathew JP, Fontes ML, Tudor IC, et al: A multicenter risk index for atrial fibrillation after cardiac surgery: JAMA291:1720-1729, 2004.
5.
Aranki SF, Shaw DP, Adams DH, et al: Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation94:390-397, 1996.
6.
Creswell LL, Schuessler RB, Rosenbloom M, et al: Hazards of postoperative atrial arrhythmias. Ann Thorac Surg56:539-549, 1993.
7.
Lahey SJ, Campos CT, Jennings B, et al: Hospital readmission after cardiac surgery. Does “fast track” cardiac surgery result in cost saving or cost shifting?Circulation98:35-40, 1998.
8.
Zaman AG, Archbold RA, Helft G, et al: Atrial fibrillation after coronary artery bypass surgery: A model for preoperative risk stratification. Circulation101:1403-1408, 2000.
9.
Hogue CW Jr, Hyder ML: Atrial fibrillation after cardiac operation: Risks, mechanisms, and treatment. Ann Thorac Surg69:300-306, 2000.
10.
Stanley TO, Mackensen GB, Grocott HP, et al: The impact of postoperative atrial fibrillation on neurocognitive outcome after coronary artery bypass graft surgery. Anesth Analg94:290-295, 2002.
11.
Kim MH, Deeb GM, Morady F, et al: Effect of postoperative atrial fibrillation on length of stay after cardiac surgery. Am J Cardiol87:881-885, 2001.
12.
Allessie MA, Boyden PA, Camm AJ, et al: Pathophysiology and prevention of atrial fibrillation. Circulation103:769-777, 2001.
13.
Wijffels MC, Kirchhof CJ, Dorland R, et al: Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation92:1954-1968, 1995.
14.
Schotten U, Duytschaever M, Ausma J, et al: Electrical and contractile remodeling during the first days of atrial fibrillation go hand in hand. Circulation107:1433-1439, 2003.
15.
Schotten U, Ausma J, Stellbrink C, et al: Cellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillation. Circulation103:691-698, 2001.
16.
Yu WC, Lee SH, Tai CT, et al: Reversal of atrial electrical remodeling following cardioversion of long-standing atrial fibrillation in man. Cardiovasc Res42:470-476, 1999.
17.
Brundel BJ, Van Gelder IC, Henning RH, et al: Ion channel remodeling is related to intraoperative atrial effective refractory periods in patients with paroxysmal and persistent atrial fibrillation. Circulation103:684-690, 2001.
18.
Lai LP, Su MJ, Lin JL, et al: Down-regulation of L-type calcium channel and sarcoplasmic reticular Ca(2+)-ATPase mRNA in human atrial fibrillation without significant change in the mRNA of ryanodine receptor, calsequestrin and phospholamban: An insight into the mechanism of atrial electrical remodeling. J Am Coll Cardiol33:1231-1237, 1999.
19.
Carnes CA, Chung MK, Nakayama T, et al: Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ Res89:32-38, 2001.
20.
Gaudino M, Andreotti F, Zamparelli R, et al: The -174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication?Circulation108:195-199, 2003.
21.
Aviles RJ, Martin DO, Apperson-Hansen C, et al: Inflammation as a risk factor for atrial fibrillation. Circulation. 108:3006-3010, 2003.
22.
Franz MR, Cima R, Wang D, et al: Electrophysiological effects of myocardial stretch and mechanical determinants of stretch-activated arrhythmias. Circulation86:968-978, 1992.
23.
Skubas NJ, Barzilai B, Hogue CW: Atrial fibrillation after coronary artery bypass graft surgery is unrelated to cardiac abnormalities detected by transesophageal echocardiography. Anesth Analg93:14-19, 2001.
24.
Shore-Lesserson L, Moskowitz D, Hametz C, et al: Use of intraoperative transesophageal echocardiography to predict atrial fibrillation after coronary artery bypass grafting. Anesthesiology95:652-658, 2001.
25.
Haissaguerre M, Jais P, Shah DC, et al: Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med339:659-666, 1998.
26.
Tsai CF, Tai CT, Chen SA: Pulmonary vein ablation: Role in preventing atrial fibrillation. Curr Opin Cardiol18:39-46, 2003.
27.
Kalifa J, Jalife J, Zaitsev AV, et al: Intra-atrial pressure increases rate and organization of waves emanating from the Superior Pulmonary Veins During Atrial Fibrillation. Circulation108:668-667, 2003.
28.
Mullen JC, Khan N, Weisel, et al: Atrial activity during cardioplegia and postoperative arrhythmias. J Thorac Cardiovasc Surg94:558-565, 1987.
29.
Wu ZK, Iivainen T, Pehkonen E, et al: Fibrillation in patients subjected to coronary artery bypass grafting. J Thorac Cardiovasc Surg126:1477-1482, 2003.
30.
Archbold RA, Curzen NP: Off-pump coronary artery bypass graft surgery: The incidence of postoperative atrial fibrillation. Heart89:1134-1137, 2003.
31.
Ascione R, Caputo M, Calori G, et al: Predictors of atrial fibrillation after conventional and beating heart coronary surgery: A prospective, randomized study. Circulation102:1530-1535, 2000.
32.
van Dijk D, Nierich AP, Jansen EW, et al: Early outcome after off-pump versus on-pump coronary bypass surgery: Results from a randomized study. Circulation104:1761-1766, 2001.
33.
Salamon T, Michler RE, Knott KM, et al: Off-pump coronary artery bypass grafting does not decrease the incidence of atrial fibrillation. Ann Thorac Surg75:505-507, 2003.
34.
Place DG, Peragallo RA, Carroll J, et al: Postoperative atrial fibrillation: A comparison of off-pump coronary artery bypass surgery and conventional coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth16:144-148, 2002.
35.
Kalman JM, Munawar M, Howes LG, et al: Atrial fibrillation after coronary artery bypass grafting is associated with sympathetic activation. Ann Thorac Surg60:1709-1715, 1995.
36.
Jayachandran JV, Sih HJ, Winkle W, et al: Atrial fibrillation produced by prolonged rapid atrial pacing is associated with heterogeneous changes in atrial sympathetic innervation. Circulation101:1185-1191, 2000.
37.
Herweg B, Dalal P, Nagy B, et al: Power spectral analysis of heart period variability of preceding sinus rhythm before initiation of paroxysmal atrial fibrillation. Am J Cardiol82:869-874, 1998.
38.
Hogue CW Jr, Domitrovich PP, Stein PK, et al: RR interval dynamics before atrial fibrillation in patients after coronary artery bypass graft. Circulation98:429-434, 1998.
39.
Liu L, Nattel S: Differing sympathetic and vagal effects on atrial fibrillation in dogs: Role of refractoriness heterogeneity. Am J Physiol273:805-816, 1997.
40.
Cummings JE, Gill I, Akhrass R, et al: Preservation of the anterior fat pad paradoxically decreases the incidence of postoperative atrial fibrillation in humans. J Am Coll Cardiol43:994-1000, 2004.
41.
Fuster V, Ryden LE, Asinger RW, et al: American College of Cardiology/American Heart Association/European Society of Cardiology Board. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: Executive summary. J Am Coll Cardiol38:1231-1266, 2001.
42.
VanderLugt JT, Mattioni T, Denker S, et al: Efficacy and safety of ibutilide fumarate for the conversion of atrial arrhythmias after cardiac surgery. Circulation100:369-375, 1999.
43.
Frost L, Mortensen PE, Tingleff J, et al: Efficacy and safety of dofetilide, a new class III antiarrhythmic agent, in acute termination of atrial fibrillation or flutter after coronary artery bypass surgery. Int J Cardiol58:135-140, 1997.
44.
Wyse DG, Waldo AL, DiMarco JP, et al: Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med347:1825-1833, 2002.
45.
Carlsson J, Miketic S, Windeler J, et al: Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: The strategies of treatment of atrial fibrillation (STAF) study. J Am Cardiol41:1690-1696, 2003.
46.
Echt DS, Liebson PR, Mitchell LB, et al: Mortality and morbidity in patients receiving encainide, flecainide or placebo. The Cardiac Arrhythmias Suppression Trial. N Engl J Med324:781-788, 1991.
47.
Page RL, Kerber RE, Russell JK, et al: Biphasic versus monophasic shock waveform for conversion of atrial fibrillation: The results of an international randomized, doubleblind multicenter trial. J Am Coll Cardiol39:1956-1963, 2002.
48.
Bechtel JF, Christiansen JF, Sievers HH, et al: Low-energy cardioversion versus medical treatment for the termination of atrial fibrillation after CABG. Ann Thorac Surg75:1185-1188, 2003.
49.
Hogue CW Jr, Murphy SF, Schechtman KB, et al: Risk factors for early or delayed stroke after cardiac surgery. Circulation100:642-647, 1999.
50.
van Walraven C, Hart RG, Singer DE, et al: Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: An individual patient meta-analysis. JAMA288:2441-2448, 2002.
51.
Troughton RW, Asher CR, Klein AL: The role of echocardiography in atrial fibrillation and cardioversion. Heart89:1447-1454, 2003.
52.
Rawles JM: What is meant by a “controlled” ventricular rate in atrial fibrillation?Br Heart J63:157-161, 1990.
53.
Moran JL, Gallagher J, Peake SL, et al: Parental magnesium sulphate versus amiodarone in the therapy of atrial tachyarrhythmias: A prospective, randomised study. Crit Care Med23:1816-1824, 1995.
54.
Hjelms E: Procainamide conversion of acute atrial fibrillation after open-heart surgery compared with digoxin treatment. Scand J Thorac Cardiovasc Surg26:193-196, 1992.
55.
Connolly SJ: Evidence-based analysis of amiodarone efficacy and safety. Circulation100:2025-2034, 1999.
56.
Larbuisson R, Venneman I, Stiels B: The efficacy and safety of intravenous propafenone versus intravenous amiodarone in the conversion of atrial fibrillation or flutter after cardiac surgery. J Cardiothorac Vasc Anesth10:229-234, 1996.
57.
Di Biasi P, Scrofani R, Paje A, et al: Intravenous amiodarone vs propafenone for atrial fibrillation and flutter after cardiac operation. Eur J Cardiothorac Surg9:587-591, 1995.
Soucier R, Silverman D, Abordo M, et al: Propafenone versus ibutilide for post operative atrial fibrillation following cardiac surgery: Neither strategy improves outcomes compared to rate control alone (the PIPAF study). Med Sci Monit9:19-23, 2003.
60.
Singh S, Zoble RG, Yellen L, et al: Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: The symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study. Circulation102:2385-2390, 2000.
61.
Pedersen OD, Bagger H, Keller N, et al: Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: A Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy. Circulation104:292-296, 2001.
62.
Pratt CM, Singh SN, Al-Khalidi HR, et al: The efficacy of azimilide in the treatment of atrial fibrillation in the presence of left ventricular systolic dysfunction. J Am Coll Cardiol43:1211-1216, 2004.
